Results 231 to 240 of about 345,978 (380)

Neuroinflammation as a risk factor for attention deficit hyperactivity disorder

open access: yesPharmacology, Biochemistry and Behavior, 2019
G. Dunn, J. Nigg, E. Sullivan
semanticscholar   +1 more source

A comprehensive longitudinal analysis of changes during Attention Deficit Hyperactive Disorder pharmacological treatments: Relationships between clinical measures, QbCheck and Conners CPT‐II

open access: yesJCPP Advances, EarlyView.
Abstract Background This study aims to evaluate the clinical value of using QbCheck in routine Attention Deficit Hyperactive Disorder (ADHD) clinics by investigating longitudinal inter‐domain relationships between objective neurocognitive outcomes of QbCheck and subjective clinical outcomes: ADHD core symptoms, impairment and quality of life (QoL ...
Seungjae Lee   +3 more
wiley   +1 more source

Systematic review: Safety and efficacy of atomoxetine in children and adolescents with autism spectrum disorder

open access: yesJCPP Advances, EarlyView.
This systematic review aimed to assess the current evidence on the efficacy and safety of Atomoxetine in common clinical symptoms of autism spectrum disorder (ASD) for children and adolescents. With limited studies available, there is a need for more high‐power studies for the use of Atomoxetine in children and adolescents with autism spectrum disorder.
Nihit Gupta   +3 more
wiley   +1 more source

Comparison of ADOS-2 scores in adults with attention deficit hyperactivity disorder and autism spectrum disorder. [PDF]

open access: yesPCN Rep
Hanawa Y   +8 more
europepmc   +1 more source

Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples [PDF]

open access: bronze, 2001
Sarah Curran   +15 more
openalex   +1 more source

Genetic and environmental influences on sleep quality, ability to settle, and crying duration in 2‐ and 5‐month‐old infants: A longitudinal twin study

open access: yesJCPP Advances, EarlyView.
This study found that genetic factors largely influence crying duration and settle ability in infancy, while shared environmental factors primarily affect the number of night wakeups. Etiological influences tended to change from 2 to 5 months, reflecting a highly plastic period in infant brain development and in child‐environment interactions. Abstract
Charlotte Viktorsson   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy